Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Creatine is a molecule that supports energy metabolism in cells. It is carried across the plasma membrane by the creatine transporter. There has been recent interest in creatine for its neuroprotective effects in neurodegenerative diseases and its potential as a therapeutic agent. This study represents the first systematic investigation of the distribution of the creatine transporter in the human brain. We have used immunohistochemical techniques to map out its location and the intensity of staining. The transporter was found to be strongly expressed, especially in the large projection neurons of the brain and spinal cord. These include the pyramidal neurons in the cerebral cortex, Purkinje cells in the cerebellar cortex, and motor neurons of the somatic motor and visceromotor cranial nerve nuclei and the ventral horn of the spinal cord. Many other neurons in the brain also had some degree of creatine transporter immunoreactivity. By contrast, the medium spiny neurons of the striatum and the catecholaminergic neurons of the substantia nigra and locus coeruleus, which are implicated in neurodegenerative diseases, showed a very low to almost absent level of immunoreactivity for the transporter. We propose that the distribution may reflect the energy consumption by different cell types and that the extent of creatine transporter expression is proportional to the cell's energy requirements. Furthermore, the distribution indicates that supplemented creatine would be widely taken up by brain cells, although possibly less by those cells that degenerate in Huntington's and Parkinson's diseases. J. Comp. Neurol. 523:699–725, 2015. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Energy Budget for Signaling in the Grey Matter of the Brain
Attwell, D., & Laughlin, S. B. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00001 · Cited by 3,543 · cited 7×
“Throughout the brain, CrT appears to be expressed predominantly in neurons, with some degree of expression in oligodendrocytes and endothelial cells of the blood–brain barrier but not in astrocytes (Braissant et al., 2001, 2010; Mak et al., 2009; Tachikawa et al., 2004).”
BackgroundResultInfluentialCreatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021
The cost of cortical computation.
Lennie, P. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00135-0 · Cited by 1,134 · cited 3×
“Computed energy budgets, which integrate physiological data into models of cellular and regional energy use, provide an interesting comparison with the current CrT distribution data (Attwell and Laughlin, 2001; Howarth et al., 2009; Lennie, 2003; Nawroth et al., 2007).”
BackgroundMethodCNS energy metabolism as related to function
Ames, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00038-2 · Cited by 663
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0406 · Cited by 293
Dedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01706.x · Cited by 169 · cited 1×
“…for both these diseases under the tacit assumption that it is the uptake of Cr into these neurons that is responsible for the neuroprotective effects observed in animal models (Andreassen et al., 2001; Dedeoglu et al., 2003; Ferrante et al., 2000; Matthews et al., 1998, 1999; Shear et al., 2000).”
BackgroundEffect of Oral Creatine Supplementation on Human Muscle GLUT4 Protein Content After Immobilization
Eijnde, B. O. '., Ursø, B., Richter, E. A., Greenhaff, P. L., & Hespel, P. (2001) · Diabetes · doi:10.2337/diabetes.50.1.18 · Cited by 162
Cited by
Creatine for neuroprotection in neurodegenerative disease: end of story?
Bender, A., & Klopstock, T. (2016) · Amino Acids · doi:10.1007/s00726-015-2165-0 · Cited by 96
“they should be susceptible to Cr neuroprotection (Lowe et al. 2015).”
BackgroundInfluentialKondo, D. G., Forrest, L. N., Shi, X., Sung, Y.-H., Hellem, T. L., Huber, R. S., & Renshaw, P. F. (2016) · Amino Acids · doi:10.1007/s00726-016-2194-3 · Cited by 79
A review of creatine supplementation in age-related diseases: more than a supplement for athletes
Smith, R. N., Agharkar, A. S., & Gonzales, E. B. (2014) · F1000Research · doi:10.12688/f1000research.5218.1 · Cited by 82
“From the plasma, creatine is transported into the cells via the creatine transporter protein (CRT) 6,7 .”
BackgroundHanna-El-Daher, L., & Braissant, O. (2016) · Amino Acids · doi:10.1007/s00726-016-2189-0 · Cited by 65
Effect of Creatine Supplementation Dosing Strategies on Aging Muscle Performance
Chami, J., & Candow, D. G. (2019) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1148-8 · Cited by 27
Metadata
- Authors
- Lowe, M. T. J., Faull, R. L. M., Christie, D. L., & Waldvogel, H. J.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2014-09-12
- Volume
- 523
- Issue
- 5
- Pages
- 699-725
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W1608879020
- Cited by
- 54
- References
- 11
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity. https://app.cochat.ai/papers/10.1002/cne.23667
- The paper
- Lowe, M. T. J., Faull, R. L. M., Christie, D. L., & Waldvogel, H. J. (2015). Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity. Journal of Comparative Neurology. https://doi.org/10.1002/cne.23667
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.